This award provides protected time to mid-career clinical investigators who at the time of application are associate professors or full professors within 10 years of their appointment as an Associate Professor and who have their own independent peer-reviewed research support to provide mentoring to junior clinical investigators, particularly K23 grantees, in patient-oriented research and to stabilize the careers of these investigators so that they could continue to conduct patient-oriented research and be available as mentors in patient-oriented research.
It is expected that the K24 recipients will obtain new or additional independent peer-reviewed funding for patient-oriented research as a Program Director/Principal Investigator and establish and assume leadership roles in collaborative patient-oriented research programs. In addition, it is expected that there will be an increased effort and commitment to act as a mentor to beginning clinician investigators in patient-oriented research to enhance the research productivity of both the K24 investigator and increase the pool of well-trained clinical researchers of the future.
Candidates for this award must have a health-professional doctoral degree or its equivalent. Such degrees include but are not limited to the M.D., D.O., D.D.S., D.M.D., O.D., D.C., Pharm.D., N.D. (Doctor of Naturopathy), as well as a doctoral degree in nursing. Candidates with Ph.D. degrees are eligible for this award if the degree is in a clinical field or they perform patient-oriented research (POR). This may include clinical psychologists, clinical geneticists, speech and language pathologists.
Midcareer Investigator Award in Patient-Oriented Research (K24) Web link: K24 Program Announcement (PA-14-047).
Who is eligible? At the time of application, individuals who are associate professors or full professors within 10 years of their appointment as an Associate Professor are eligible to submit a new NHLBI K24 application. The NHLBI will consider requests to extend the eligibility period for reasons that can include medical concerns, disability, family care responsibilities, natural disasters, and active duty military service. In general, the NHLBI will extend eligibility for a period equivalent to the time away from faculty service. Extensions related to periods of part-time status normally will be prorated to reflect the actual time away from faculty service and normally will be considered only when the appointment is reduced by 50% or more for a sustained period of time.
The K24 applicant (new or renewal) is required to have an active, independent, peer-reviewed R01 or R01-like grant funding, which includes peer-reviewed research grants from other federal sources, private foundations, or industry at the time of application. Grants under a no-cost extension do not qualify. The PI is expected to maintain such research grant support during the project period.
An individual who holds R01 or R01-like funding, with a major focus on the analysis of large-scale clinical or population data, is eligible to apply provided the patient-oriented research (POR) requirements are met and the PI proposes a research plan that will include POR training opportunities for mentees.
Candidates must be U.S. citizens, non-citizen nationals, or legal permanent residents of the U.S.
The opportunities? Conduct patient-oriented research and act as research mentors.
Duration of support? 3 to 5 years. In addition to new applications, NHLBI will now accept renewal K24 applications that request 3.0 calendar months' (25% of full-time professional effort). Applications requesting more than 3.0 calendar months' (25% of full-time professional effort) will not be reviewed. The NHLBI K24 award may be renewed one time.
Where? Domestic non-Federal organizations, public or private, such as medical, dental or nursing schools or other institutions of higher education.
Applications due? February 12, June 12, and October 12 - new applications;
March 12, July 12, and November 12 - renewal and resubmission applications.
Salary: The salary that may be requested and awarded is 25% of the recipient's institutional salary, exclusive of fringe benefits, up to the maximum allowable annual salary rate in effect at the time of award. NIH issues an annual notice of the maximum allowable salary rate in the NIH Guide.
Research Development Support: Up to $50,000 per year
How to apply: Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be submitted electronically through Grants.gov (http://www.grants.gov) using the SF 424 Research and Related (R&R) forms and the SF 424 (R&R) Application Guide.
Resources for K24 Candidates:
Please contact the following NHLBI staff member if you have questions about this award:
Sandra Colombini Hatch, M.D.
Division of Lung Diseases (responding for all NHLBI programmatic Divisions)
National Heart, Lung, and Blood Institute
Two Rockledge Center
6701 Rockledge Drive, MSC 7952
Bethesda, Maryland 20892-7952
Phone: (301) 435-0222
FAX: (301) 480-3557
Revised: June 2015